Types of Lipids
Links shared publicly online about this topic
TYPE 1 LIPID LEVELS? - TuDiabetes
tudiabetes.org — “I have had T1 for 34 years (I am 41 now.) I had a kidney transplant 5 yars ago (successful) and was not required to take prednisone. I also hve had two toes amputated (in 99) and a round of retinopathy twenty years ago that thankfull did no take my sight. OK,...I am petite (5 ft 0 in, 108lbs BMI 21) My lipid profles have always come back in range. Last week it looked like this: Chol: 128 Trig 34 HDL 48 LDL 73 Chol/HDL ratio 2.7. Hgb A1c 6.7. I guess I just dont get it? Am I missing something? It” View full resource at tudiabetes.org
Most Recently Shared on December 5, 2009 at 7:24 am By:
TuDiabetes blogs: TYPE 1 LIPID LEVELS?: I have had T1 for 34 years (I am 41 now.) I had a kidney transplant 5 yars ... http://bit.ly/7QIxGU
Nuts and blood lipid levels
theheart.org — “The findings, according to researchers, confirm that nuts, as part of a healthy diet, favorably affect blood lipid levels and have the potential to lower coronary heart disease risk.” View full resource at theheart.org
Most Recently Shared on May 10, 2010 at 8:41 pm By:
Let's get nuts! Eating almonds, walnuts, pecans, and other nuts improves lipid levels: The findings, according to ... http://bit.ly/dr7WRp
Endocrinology Article | Lipids
mdlinx.com — “A longitudinal assessment of lipids in youth with type 1 diabetes” View full resource at mdlinx.com
Most Recently Shared on March 16, 2011 at 5:23 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A longitudinal assessment of lipids in youth with type 1 diabetes: Pediatric Diabetes http://bit.ly/fXBDVq #endo
Disappearance of Angina Pectoris by Lipid-Lowering in Type III Hyperlipoproteinemia
peerview-institute.org — “Disappearance of Angina Pectoris by Lipid-Lowering in Type III Hyperlipoproteinemia” View full resource at peerview-institute.org
Most Recently Shared on January 25, 2011 at 1:47 pm By:
James Underberg Internist, Physician, and Doctor
Disappearance of Angina Pectoris by Lipid-Lowering in Type III Hyperlipoproteinemia http://goo.gl/B5Jsf
Aggressive lipid control fails to benefit type 2 diabetics - - Drug Topics
drugtopics.modernmedicine.com — “Adding fenofibrate to statin therapy fails to reduce cardiovascular events in patients with type 2 diabetes, according to results of the first trial to evaluate combination therapy presented at the 59th annual scientific session of the American College of Cardiology.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on June 12, 2010 at 7:09 pm By:
Aggressive lipid control fails to benefit type 2 diabetics: Adding fenofibrate to statin therapy fails to reduce c... http://bit.ly/diiusi
ACCORD Lipid trial: New research into atherogenic dyslipidemia in type 2 diabetes
news-medical.net — “Cardiovascular risk can be reduced by an additional 31 percent in type 2 diabetes patients with atherogenic dyslipidemia, the common combination of elevated triglycerides (TG, 204 mg/dL or 2.3 mmol/L or higher) and low levels of high-density lipoprotein cholesterol (HDL-C, 34 mg/dL or 0.88 mmol/L or lower).” View full resource at news-medical.net
Most Recently Shared on March 15, 2010 at 4:57 am By:
ACCORD Lipid trial: New research into atherogenic dyslipidemia in type 2 diabetes: Cardiovascular risk can be redu... http://bit.ly/af604z
ACCORD Lipid Study Brings New Hope To People With Type 2 Diabetes And Atherogenic Dyslipidemia Says International Academic Foundation
medicalnewstoday.com — “Cardiovascular risk can be reduced by an additional 31 percent in type 2 diabetes patients with atherogenic dyslipidemia, the common combination of elevated triglycerides (TG, 204 mg/dL or 2.3 mmo” View full resource at medicalnewstoday.com
Most Recently Shared on March 17, 2010 at 3:11 pm By:
MNT Cholesterol News Health News
ACCORD Lipid Study Brings New Hope To People With Type 2 Diabetes And Atherogenic Dyslipidemia Says International Acad... http://mnt.to/3z37
ACCORD Lipid Study Brings new Hope to People With Type... -- ATLANTA, Georgia, March 14, 2010 /PRNewswire/ --
prnewswire.com — “ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation.” View full resource at prnewswire.com
Most Recently Shared on March 14, 2010 at 4:08 pm By:
ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia http://bit.ly/bYFGDs /via @AllisonHarkett
Practical Diabetology Highlights Advanced Lipid Testing For Type 2 Diabetes Patients - QualityPoint Technologies
qualitypointtech.net — “The article discusses the clinical advantages of advanced cholesterol testing in reducing cardiovascular disease (CVD) risk in patients with Type 2 diabetes and details several currently available advanced lipid tests, including the VAP Cholesterol Test from Atherotech. Cobble also explores which patients are appropriate to test and how to apply advanced lipid testing results...” View full resource at qualitypointtech.net
Most Recently Shared on September 18, 2010 at 12:49 pm By:
Practical Diabetology Highlights Advanced Lipid Testing For Type 2 Diabetes Patients: The article discusses the cl... http://bit.ly/ciq7ie
Symposier - Insidermedicine In Depth - Lipid Control and Eye Disease
symposier.com — “Uploaded and shared in Youtube by: insidermedicine " Carefully controlling blood sugar and cholesterol levels but not blood pressure can help preserve vision among individuals with type 2 diabetes, according to research published in the New England Journal of Medicine. Here is some information about diabetic retinopathy: It is a condition in which blood vessels in the retina of the eye are damaged due to diabetes It is a leading cause of blindness in North America It is a progressive disease in ” View full resource at symposier.com
Most Recently Shared on July 7, 2010 at 1:45 am By:
Symposier Endocrino Health Site
Insidermedicine In Depth - Lipid Control and Eye Disease. http://bit.ly/ddKQ7L
Intensive BP, Combined Lipid Therapies Do Not Help Adults With Diabetes
medicalnewstoday.com — “Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with typ” View full resource at medicalnewstoday.com
Most Recently Shared on March 15, 2010 at 2:06 pm By:
Intensive BP, Combined Lipid Therapies Do Not Help Adults With Diabetes http://mnt.to/3yVd #diabetes
NEJM -- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
content.nejm.org — “Original Article from The New England Journal of Medicine -- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus” View full resource at content.nejm.org
Most Recently Shared on March 15, 2010 at 1:21 am By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Combination of fibrate and statin is not superior to statin alone in DM2 - http://bit.ly/9gplMk
NEJM -- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
content.nejm.org — “Original Article from The New England Journal of Medicine -- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus” View full resource at content.nejm.org
Most Recently Shared on March 14, 2010 at 2:01 pm By:
More on ACCORD - no benefits to adding fibrate to statin in diabetes http://content.nejm.org/cgi/content/full/NEJMoa1001282 AW
Liraglutide and sitagliptin both good choices for type 2 diabetes | theheart.org theHeart.org: Lipid and Metabolic news related to heart conditions.
theheart.org — “Studies and Clinical trials on Metabolic and Lipid issues affecting the heart. Articles by heartwire staff and renowned cardiologists. Partnership with Baylor.” View full resource at theheart.org
Most Recently Shared on September 25, 2010 at 1:26 pm By:
Liraglutide and sitagliptin both have role to play in diabetes: Two relatively new agents for type 2 diabetes have... http://bit.ly/91Kd4Z
Liraglutide and sitagliptin both good choices for type 2 diabetes | theheart.org theHeart.org: Lipid and Metabolic news related to heart conditions.
theheart.org — “Studies and Clinical trials on Metabolic and Lipid issues affecting the heart. Articles by heartwire staff and renowned cardiologists. Partnership with Baylor.” View full resource at theheart.org
Most Recently Shared on September 27, 2010 at 8:23 am By:
Liraglutide and sitagliptin both have role to play in diabetes: Two relatively new agents for type 2 diabetes have... http://bit.ly/dxzsKi
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
a diabetes community
A nonprofit social network with nearly 20K members touched by diabetes run by @DiabetesHF. Some tweets: FC (Fabiana Couto), MH (Manny Hernandez).
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
